ARGX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

argenx NV ADR

NASDAQ | ARGX

832.35

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$52.04B

Market Cap

35.57

P/E Ratio

23.4

EPS

$855.46

52 Week High

$510.06

52 Week Low

HEALTHCARE

Sector

ARGX Chart

Recent Chart
Price Action

ARGX Technicals

Tags:

ARGX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2B
Total Revenue $2.2B
Cost Of Revenue $227M
Costof Goods And Services Sold $227M
Operating Income -$22M
Selling General And Administrative $745M
Research And Development $983M
Operating Expenses $2B
Investment Income Net -
Net Interest Income $136M
Interest Income $139M
Interest Expense $2.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $18M
Income Before Tax $85M
Income Tax Expense -$748M
Interest And Debt Expense -
Net Income From Continuing Operations $833M
Comprehensive Income Net Of Tax -
Ebit $88M
Ebitda $105M
Net Income $833M

Revenue & Profitability

Earnings Performance

ARGX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $6.2B
Total Current Assets $4.9B
Cash And Cash Equivalents At Carrying Value $1.5B
Cash And Short Term Investments $1.5B
Inventory $407M
Current Net Receivables $909M
Total Non Current Assets $1.3B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $181M
Intangible Assets Excluding Goodwill $181M
Goodwill $6.3M
Investments -
Long Term Investments $50M
Short Term Investments $1.9B
Other Current Assets $188M
Other Non Current Assets -
Total Liabilities $704M
Total Current Liabilities $670M
Current Accounts Payable $483M
Deferred Revenue -
Current Debt -
Short Term Debt $6.5M
Total Non Current Liabilities $34M
Capital Lease Obligations $39M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $39M
Other Current Liabilities $167M
Other Non Current Liabilities -
Total Shareholder Equity $5.5B
Treasury Stock -
Retained Earnings -$1.6B
Common Stock $7M
Common Stock Shares Outstanding $65M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$83M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $18M
Capital Expenditures $68M
Change In Receivables -
Change In Inventory -$96M
Profit Loss -
Cashflow From Investment -$718M
Cashflow From Financing $280M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$22M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $833M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2B
Total Revenue $2.2B
Cost Of Revenue $227M
Costof Goods And Services Sold $227M
Operating Income -$22M
Selling General And Administrative $745M
Research And Development $983M
Operating Expenses $2B
Investment Income Net -
Net Interest Income $136M
Interest Income $139M
Interest Expense $2.2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $18M
Income Before Tax $85M
Income Tax Expense -$748M
Interest And Debt Expense -
Net Income From Continuing Operations $833M
Comprehensive Income Net Of Tax -
Ebit $88M
Ebitda $105M
Net Income $833M

ARGX News

ARGX Profile

argenx NV ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

argenx NV, headquartered in Breda, the Netherlands, is a pioneering clinical-stage biotechnology firm dedicated to developing innovative antibody-based therapies for severe autoimmune diseases, hematological disorders, and cancer. The company utilizes its proprietary technology platform to advance promising candidates through various clinical trial phases, aiming to deliver transformative treatments that address significant unmet medical needs. With a robust pipeline and a strategic focus on leveraging scientific breakthroughs, argenx offers an attractive investment opportunity for institutional investors looking to capitalize on the growth potential of the biopharmaceutical industry.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+16.80%
$1.46
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
GPUS
+11.61%
$0.39
PFE
+1.27%
$24.61
RUBI
-49.75%
$0.30
VHAI
0.00%
$0.00
BYND
-4.51%
$1.27
PLUG
+4.76%
$2.64
SNAP
-2.27%
$7.30
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
SLDP
+51.55%
$8.51
F
+2.50%
$13.11
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
PINS
-21.75%
$25.75
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.10%
$9.57
T
+0.49%
$24.56
AAL
+6.08%
$13.42
SMCI
-11.32%
$42.03
BITF
+5.72%
$4.05
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
TEVA
+20.23%
$24.60
BAC
-2.03%
$52.45
NFE
+10.37%
$1.49
ETHD
-14.82%
$4.48
ADAP
-15.14%
$0.05
AMCR
+2.54%
$8.07
DVLT
-10.11%
$1.60
BTG
+0.75%
$4.03
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
QS
+10.55%
$17.07
AAPL
+0.03%
$270.14
RIG
0.00%
$3.90
CAN
+16.21%
$1.29
U
+18.09%
$42.36
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
WULF
+2.33%
$15.36
FUBO
+10.86%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
BURU
+0.20%
$0.29
NVO
+0.43%
$48.46
EPWK
-6.41%
$0.07
TLRY
+3.22%
$1.28
HIMS
+2.19%
$43.73
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
NIO
+1.81%
$7.29
PCG
+0.68%
$16.27
BMNR
+4.96%
$41.42
NCLH
-0.95%
$18.61
ZDAI
+13.94%
$0.52
PGHL
+13.94%
$0.52
RIOT
-1.58%
$18.97
JOBY
+1.62%
$15.00
NOK
+0.58%
$6.85
HTZ
-0.81%
$6.67
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
ALIT
-7.03%
$2.50
QBTS
+4.30%
$31.02
NGD
+2.40%
$6.80
GOOGL
+2.43%
$284.31
HOOD
+4.15%
$142.47
BBD
+3.62%
$3.53
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
IONZ
-7.60%
$4.13
SOUN
+3.89%
$15.72
HPE
+0.63%
$23.71
AG
-7.69%
$10.67
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
CPNG
-5.94%
$30.22
PBR
+2.62%
$12.14
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+16.80%
$1.46
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
GPUS
+11.61%
$0.39
PFE
+1.27%
$24.61
RUBI
-49.75%
$0.30
VHAI
0.00%
$0.00
BYND
-4.51%
$1.27
PLUG
+4.76%
$2.64
SNAP
-2.27%
$7.30
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
SLDP
+51.55%
$8.51
F
+2.50%
$13.11
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
PINS
-21.75%
$25.75
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.10%
$9.57
T
+0.49%
$24.56
AAL
+6.08%
$13.42
SMCI
-11.32%
$42.03
BITF
+5.72%
$4.05
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
TEVA
+20.23%
$24.60
BAC
-2.03%
$52.45
NFE
+10.37%
$1.49
ETHD
-14.82%
$4.48
ADAP
-15.14%
$0.05
AMCR
+2.54%
$8.07
DVLT
-10.11%
$1.60
BTG
+0.75%
$4.03
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
QS
+10.55%
$17.07
AAPL
+0.03%
$270.14
RIG
0.00%
$3.90
CAN
+16.21%
$1.29
U
+18.09%
$42.36
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
WULF
+2.33%
$15.36
FUBO
+10.86%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
BURU
+0.20%
$0.29
NVO
+0.43%
$48.46
EPWK
-6.41%
$0.07
TLRY
+3.22%
$1.28
HIMS
+2.19%
$43.73
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
NIO
+1.81%
$7.29
PCG
+0.68%
$16.27
BMNR
+4.96%
$41.42
NCLH
-0.95%
$18.61
ZDAI
+13.94%
$0.52
PGHL
+13.94%
$0.52
RIOT
-1.58%
$18.97
JOBY
+1.62%
$15.00
NOK
+0.58%
$6.85
HTZ
-0.81%
$6.67
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
ALIT
-7.03%
$2.50
QBTS
+4.30%
$31.02
NGD
+2.40%
$6.80
GOOGL
+2.43%
$284.31
HOOD
+4.15%
$142.47
BBD
+3.62%
$3.53
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
IONZ
-7.60%
$4.13
SOUN
+3.89%
$15.72
HPE
+0.63%
$23.71
AG
-7.69%
$10.67
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
CPNG
-5.94%
$30.22
PBR
+2.62%
$12.14
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.